The JIS system was created in 2003 by the Liver Cancer Study Group of Japan (LCSGJ) and was later improved upon and modified in TNM (JIS-TNM-Child) and JIS-TNM-Child plus alpha fetoprotein (JISTNMAFPChild). This evidence concerns the gene AFP and liver cancer.